Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Takeuchi

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
JOP : Journal of the Pancreas|September 11, 2013
Synchronous triple cancers of the pancreas, stomach, and cecum treated with S-1 followed by pancrelipase treatment of pancreatic exocrine insufficiencyKoushiro Ohtsubo, Daisuke Ishikawa, Shigeki Nanjo, et al.
Cancer Medicine|March 31, 2023
FIGHT-102: A phase 1 study of pemigatinib in Japanese patients with advanced malignanciesYutaka Fujiwara, Yasutoshi Kuboki, Masayuki Furukawa, et al.
Molecular Cancer Therapeutics|July 31, 2012
Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancerTakayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada, et al.
The American Journal of Pathology|July 14, 2012
Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancerShinji Takeuchi, Wei Wang, Qi Li, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Phase I/II study of alectinib in lung cancer with RET fusion gene: study protocolShinji Takeuchi, Toshinori Murayama, Kenichi Yoshimura, et al.
Internal Medicine (Tokyo, Japan)|September 1, 2020
Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like MassKoushiro Ohtsubo, Kaname Yamashita, Naohiro Yanagimura, et al.
Plos One|May 22, 2013
mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGFDaisuke Ishikawa, Shinji Takeuchi, Takayuki Nakagawa, et al.
Molecular Cancer Therapeutics|March 31, 2019
Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient MiceRong Wang, Tadaaki Yamada, Sachiko Arai, et al.
Cancer Science|October 25, 2024
Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncologyAkihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Anticancer Research|December 3, 2024
Analysis of Methylation of Tumor-suppressive miRNAs and <i>KRAS/TP53</i> Mutations in Pancreatic JuiceKoushiro Ohtsubo, Kunio Miyake, Shigeki Sato, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
JOP : Journal of the Pancreas|September 11, 2013
Synchronous triple cancers of the pancreas, stomach, and cecum treated with S-1 followed by pancrelipase treatment of pancreatic exocrine insufficiencyKoushiro Ohtsubo, Daisuke Ishikawa, Shigeki Nanjo, et al.
Cancer Medicine|March 31, 2023
FIGHT-102: A phase 1 study of pemigatinib in Japanese patients with advanced malignanciesYutaka Fujiwara, Yasutoshi Kuboki, Masayuki Furukawa, et al.
Molecular Cancer Therapeutics|July 31, 2012
Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancerTakayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada, et al.
The American Journal of Pathology|July 14, 2012
Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancerShinji Takeuchi, Wei Wang, Qi Li, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Phase I/II study of alectinib in lung cancer with RET fusion gene: study protocolShinji Takeuchi, Toshinori Murayama, Kenichi Yoshimura, et al.
Internal Medicine (Tokyo, Japan)|September 1, 2020
Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like MassKoushiro Ohtsubo, Kaname Yamashita, Naohiro Yanagimura, et al.
Plos One|May 22, 2013
mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGFDaisuke Ishikawa, Shinji Takeuchi, Takayuki Nakagawa, et al.
Molecular Cancer Therapeutics|March 31, 2019
Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient MiceRong Wang, Tadaaki Yamada, Sachiko Arai, et al.
Cancer Science|October 25, 2024
Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncologyAkihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Anticancer Research|December 3, 2024
Analysis of Methylation of Tumor-suppressive miRNAs and <i>KRAS/TP53</i> Mutations in Pancreatic JuiceKoushiro Ohtsubo, Kunio Miyake, Shigeki Sato, et al.
Pageof 12